574 related articles for article (PubMed ID: 36778129)
21. Mitochondria-mediated energy adaption in cancer: the H(+)-ATP synthase-geared switch of metabolism in human tumors.
Sánchez-Aragó M; Formentini L; Cuezva JM
Antioxid Redox Signal; 2013 Jul; 19(3):285-98. PubMed ID: 22901241
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial and metabolic alterations in cancer cells.
Di Gregorio J; Petricca S; Iorio R; Toniato E; Flati V
Eur J Cell Biol; 2022; 101(3):151225. PubMed ID: 35453093
[TBL] [Abstract][Full Text] [Related]
23. Nutrient deprivation-related OXPHOS/glycolysis interconversion via HIF-1α/C-MYC pathway in U251 cells.
Liu Z; Sun Y; Tan S; Liu L; Hu S; Huo H; Li M; Cui Q; Yu M
Tumour Biol; 2016 May; 37(5):6661-71. PubMed ID: 26646563
[TBL] [Abstract][Full Text] [Related]
24. The role of microRNAs in mitochondria in cancer.
Bienertova-Vasku J; Sana J; Slaby O
Cancer Lett; 2013 Aug; 336(1):1-7. PubMed ID: 23665507
[TBL] [Abstract][Full Text] [Related]
25. Ketones and lactate increase cancer cell "stemness," driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo-Genomics.
Martinez-Outschoorn UE; Prisco M; Ertel A; Tsirigos A; Lin Z; Pavlides S; Wang C; Flomenberg N; Knudsen ES; Howell A; Pestell RG; Sotgia F; Lisanti MP
Cell Cycle; 2011 Apr; 10(8):1271-86. PubMed ID: 21512313
[TBL] [Abstract][Full Text] [Related]
26. The Influence of Mitochondrial Energy and 1C Metabolism on the Efficacy of Anticancer Drugs: Exploring Potential Mechanisms of Resistance.
Franczak M; Toenshoff I; Jansen G; Smolenski RT; Giovannetti E; Peters GJ
Curr Med Chem; 2023; 30(11):1209-1231. PubMed ID: 35366764
[TBL] [Abstract][Full Text] [Related]
27. Mitochondria and Cancer.
Zong WX; Rabinowitz JD; White E
Mol Cell; 2016 Mar; 61(5):667-676. PubMed ID: 26942671
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial fission induces glycolytic reprogramming in cancer-associated myofibroblasts, driving stromal lactate production, and early tumor growth.
Guido C; Whitaker-Menezes D; Lin Z; Pestell RG; Howell A; Zimmers TA; Casimiro MC; Aquila S; Ando' S; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Oncotarget; 2012 Aug; 3(8):798-810. PubMed ID: 22878233
[TBL] [Abstract][Full Text] [Related]
29. Alterations in bioenergetics due to changes in mitochondrial DNA copy number.
Qian W; Van Houten B
Methods; 2010 Aug; 51(4):452-7. PubMed ID: 20347038
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic Targeting of Tumor Cells and Tumor Immune Microenvironment Vulnerabilities.
Kalyanaraman B; Cheng G; Hardy M
Front Oncol; 2022; 12():816504. PubMed ID: 35756631
[TBL] [Abstract][Full Text] [Related]
31. Genetic alterations in Krebs cycle and its impact on cancer pathogenesis.
Sajnani K; Islam F; Smith RA; Gopalan V; Lam AK
Biochimie; 2017 Apr; 135():164-172. PubMed ID: 28219702
[TBL] [Abstract][Full Text] [Related]
32. Distinctions and similarities of cell bioenergetics and the role of mitochondria in hypoxia, cancer, and embryonic development.
Jezek P; Plecitá-Hlavatá L; Smolková K; Rossignol R
Int J Biochem Cell Biol; 2010 May; 42(5):604-22. PubMed ID: 19931409
[TBL] [Abstract][Full Text] [Related]
33. α-Lactalbumin-oleic acid complex kills tumor cells by inducing excess energy metabolism but inhibiting mRNA expression of the related enzymes.
Fang B; Zhang M; Ge KS; Xing HZ; Ren FZ
J Dairy Sci; 2018 Jun; 101(6):4853-4863. PubMed ID: 29550120
[TBL] [Abstract][Full Text] [Related]
34. Changing perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agents.
Corrado M; Scorrano L; Campello S
Oncotarget; 2016 Jul; 7(29):46692-46706. PubMed ID: 27083002
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of Mitochondrial Metabolism Leads to Selective Eradication of Cells Adapted to Acidic Microenvironment.
Koncošová M; Vrzáčková N; Křížová I; Tomášová P; Rimpelová S; Dvořák A; Vítek L; Rumlová M; Ruml T; Zelenka J
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639130
[TBL] [Abstract][Full Text] [Related]
36. Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment.
Simões RV; Serganova IS; Kruchevsky N; Leftin A; Shestov AA; Thaler HT; Sukenick G; Locasale JW; Blasberg RG; Koutcher JA; Ackerstaff E
Neoplasia; 2015 Aug; 17(8):671-84. PubMed ID: 26408259
[TBL] [Abstract][Full Text] [Related]
37. New insights into the bioenergetics of mitochondrial disorders using intracellular ATP reporters.
Gajewski CD; Yang L; Schon EA; Manfredi G
Mol Biol Cell; 2003 Sep; 14(9):3628-35. PubMed ID: 12972552
[TBL] [Abstract][Full Text] [Related]
38. Interplay between Mitochondrial Metabolism and Cellular Redox State Dictates Cancer Cell Survival.
Foo BJ; Eu JQ; Hirpara JL; Pervaiz S
Oxid Med Cell Longev; 2021; 2021():1341604. PubMed ID: 34777681
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial dysfunction and cancer metastasis.
Chen EI
J Bioenerg Biomembr; 2012 Dec; 44(6):619-22. PubMed ID: 22892817
[TBL] [Abstract][Full Text] [Related]
40. Mitochondrial metabolism-mediated redox regulation in cancer progression.
Boese AC; Kang S
Redox Biol; 2021 Jun; 42():101870. PubMed ID: 33509708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
